Neurocrine Biosciences (NASDAQ:NBIX)‘s stock had its “hold” rating restated by analysts at Needham & Company LLC in a research note issued on Monday, AnalystRatings.com reports. Other research a
Mizuho Securities analyst Mara Goldstein reiterated a Buy rating on Fate Therapeutics (FATE) today and set a price target of $40.00. The company's shares
Mizuho Securities analyst Mara Goldstein reiterated a Buy rating on Fate Therapeutics (FATE – Research Report) today and set a
Citizens National Bank Trust Department acquired a new position in QUALCOMM, Inc. (NASDAQ:QCOM) during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exc
Cognios Capital LLC reduced its stake in shares of Quest Diagnostics Inc (NYSE:DGX) by 73.0% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commi
BBVA USA Bancshares Inc. grew its position in shares of Xilinx, Inc. (NASDAQ:XLNX) by 7.5% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 17,63
Camelot Portfolios LLC increased its stake in shares of Ventas, Inc. (NYSE:VTR) by 456.7% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange
Camelot Portfolios LLC purchased a new stake in Cardinal Health Inc (NYSE:CAH) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The instit
Hudson Pacific Properties Inc (NYSE:HPP) – Equities research analysts at Piper Sandler cut their Q2 2020 earnings per share (EPS) estimates for Hudson Pacific Properties in a research report issued
Certified Advisory Corp decreased its holdings in shares of Realty Income Corp (NYSE:O) by 12.6% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 5,613 shares of t
NXP Semiconductors (NASDAQ:NXPI)‘s stock had its “buy” rating reaffirmed by investment analysts at Mizuho in a note issued to investors on Monday, AnalystRatings.com reports. They presently have
Veoneer Inc (NYSE:VNE) – Stock analysts at KeyCorp issued their Q2 2020 earnings per share estimates for shares of Veoneer in a research note issued on Sunday, April 26th. KeyCorp analyst J. Picarie
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) CEO Kevin Charles Gorman sold 2,906 shares of the firm’s stock in a transaction on Friday, April 24th. The shares were sold at an average price of $99.45,
Eli Lilly And Co (NYSE:LLY) major shareholder Lilly Endowment Inc sold 12,663 shares of Eli Lilly And Co stock in a transaction dated Monday, April 27th. The shares were sold at an average price of $1
Beirne Wealth Consulting Services LLC raised its stake in shares of JD.Com Inc (NASDAQ:JD) by 45.9% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commiss
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE